
Recent developments with KalVista Pharmaceuticals Inc (KALV) have led to the company’s beta value being reach 0.04 cents.
On Friday, KalVista Pharmaceuticals Inc (NASDAQ: KALV) was -3.08% drop from the session before settling in for the closing price of $13.63. A 52-week range